Niraxx Light Therapeutics
PrivateLast Round
Series A
Jul 1, 2024
Total Funding Raised
$68,968
Company Overview
Niraxx Light Therapeutics is a neurotech company that develops wearable healthcare products and digital platforms utilizing photobiomodulation (PBM) technology to treat mental health conditions and improve brain health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Niraxx Light Therapeutics Comparables
Compare Niraxx Light Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sens.ai Incorporated | 87% | |
| Vielight Inc. | 84% | |
| Neuronic | 83% | |
Niraxx Light Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2024 | ||||
| Crowdfunding | Apr 1, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors grew 45% MoM, reaching 1.1K.
- May 1, 2025
Monthly visitors grew 167% MoM, reaching 902.
Niraxx Light Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Niraxx Light Therapeutics's valuation, stock price, and market status.